The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT01280539
- Lead Sponsor
- Hasselt University
- Brief Summary
In this study the researchers want to investigate the effects of long-term transcutaneous electrical nerve stimulation on the cortical excitability of persons with multiple sclerosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Expanded Disability Status Scale (EDSS) scores between 2 and 6.5
- Stable MS (no relapse during the last 3 months before study onset)
- sensory impairment
- age: between 18 and 68 years old
Exclusion Criteria
- Patients with other pathologies associated with peripheral and/or central sensory dysfunction or under psychotropic or antiepileptic medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Change in cortical excitability Baseline, immediately after and 3 weeks after the intervention Cortical excitability will be assessed using transcranial magnetic stimulation (TMS)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie TENS-induced cortical excitability changes in multiple sclerosis patients?
How does long-term TENS compare to standard MS therapies like interferon beta in modulating neuroinflammatory markers?
Which biomarkers correlate with TENS response in relapsing-remitting versus progressive multiple sclerosis subtypes?
What adverse events are associated with transcutaneous electrical nerve stimulation in MS and how are they managed?
Are there synergistic effects when combining TENS with disease-modifying therapies like glatiramer acetate in MS treatment?
Trial Locations
- Locations (1)
Hasselt University (BIOMED)
🇧🇪Diepenbeek, Limburg, Belgium
Hasselt University (BIOMED)🇧🇪Diepenbeek, Limburg, Belgium